Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 26.30% vs -37.31% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 11.85% vs -6.64% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 19.90% vs -29.69% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 1.61% vs -3.21% in Mar 2025
Compare Balance Sheet Results of Link Pharma Chem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.44
9.81
-5.37
-54.74%
Share Warrants & Outstandings
Total Reserve
8.35
-3.75
12.10
322.67%
Shareholder's Funds
12.79
6.06
6.73
111.06%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.70
0.00
0.70
0.00%
Secured Loans
0.70
0.00
0.70
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.16
0.00
-0.16
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.24
0.00
0.24
0.00%
Total Non-Current Liabilities
0.77
0.00
0.77
0.00%
Current Liabilities
Trade Payables
3.25
0.00
3.25
0.00%
Other Current Liabilities
0.88
0.03
0.85
2,833.33%
Short Term Borrowings
6.61
0.00
6.61
0.00%
Short Term Provisions
0.50
0.00
0.50
0.00%
Total Current Liabilities
11.24
0.03
11.21
37,366.67%
Total Liabilities
24.81
6.08
18.73
308.06%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
18.01
0.00
18.01
0.00%
Less: Accumulated Depreciation
7.63
0.00
7.63
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.38
0.00
10.38
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.47
0.65
1.82
280.00%
Long Term Loans & Advances
0.58
0.00
0.58
0.00%
Other Non Current Assets
0.04
0.11
-0.07
-63.64%
Total Non-Current Assets
13.46
0.76
12.70
1,671.05%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
5.02
0.00
5.02
0.00%
Sundry Debtors
5.28
0.00
5.28
0.00%
Cash and Bank
0.63
1.94
-1.31
-67.53%
Other Current Assets
0.07
0.03
0.04
133.33%
Short Term Loans and Advances
0.34
3.36
-3.02
-89.88%
Total Current Assets
11.34
5.32
6.02
113.16%
Net Current Assets (Including Current Investments)
0.10
5.29
-5.19
-98.11%
Total Current Assets Excluding Current Investments
11.34
5.32
6.02
113.16%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
24.81
6.08
18.73
308.06%
Contingent Liabilities
1.61
0.28
1.33
475.00%
Total Debt
7.30
0.00
7.30
0.00%
Book Value per share (adjusted)
28.80
3.09
25.71
832.04%
Annual - Borrowings
Borrowings 7.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 26.30% vs -37.31% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.38 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.85% vs -6.64% in Mar 2025
Annual - Investments
Investments 2.47 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.90% vs -29.69% in Mar 2025
Annual - Current Assets
Current Assets 11.34 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1.61% vs -3.21% in Mar 2025






